Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Epoetin alfa may
stimulate red blood cell production and treat anemia in patients with head and neck cancer.
It is not yet known whether receiving radiation therapy with epoetin alfa is more effective
than radiation therapy alone in treating anemic patients with head and neck cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or
without epoetin alfa in treating anemic patients who have head and neck cancer.